Tolerability, Safety and Pharmacokinetic Study of Humanized Anti-CD6 Monoclonal Antibody Injection in Chinese Psoriasis
Clinical trial NCT02649270 · TERMINATED
Trial details
- NCT number
- NCT02649270
- Sponsor
- Biotech Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-06-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.